The Ontario Institute for Cancer Research (OICR) is a new center of excellence. It is moving Ontario to the forefront of discovery and innovation in cancer research. Funded by the Government of Ontario, through the Ministry of Research and Innovation, the Institute received a grant of $350 million for its first five years of operation.
Located in the MaRS Centre, in the Discovery District of Toronto, OICR is in the center of Ontario’s life sciences community. With a multi-disciplinary, multi-institutional approach to research, OICR is making rapid progress in addressing the challenges posed by cancer. The Institute has established major partnerships with public organizations such as Cancer Care Ontario in Ontario, the Terry Fox Research Institute and five federal agencies in Canada, and with the world’s foremost cancer and genome funding agencies in Asia, Australia, Europe and North America. Major corporate partners include Pfizer Global Research and GE Healthcare.
OICR’s ...
